TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
Standalone profit from operations for the quarter were Rs. 162 crores
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
This rating reflects Lupin's leadership in environmental transparency and performance
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
This transformation will enable GE HealthCare to build a strong foundation for business growth
Subscribe To Our Newsletter & Stay Updated
